Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    ANTIBODY (AB) ADVANCED MANUFACTURING CAPABILITY IMPROVEMENT: SMART TECHNOLOGIES

    Special NoticeWASHINGTON, DC
    Closed
    STATUS
    Closed
    closed Oct 1, 2025
    POSTED
    Sep 10, 2025
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    Product & service classification

    AI Summary

    The Department of Health and Human Services is seeking innovative solutions to enhance antibody manufacturing capabilities. This initiative aims to improve scalability, cost-efficiency, and adaptability in production processes using advanced technologies. Interested parties should focus on improvements applicable across multiple biologics, with oversight from BARDA.

    Contract details

    Notice Type
    Special Notice
    Posted Date
    September 10, 2025
    Response Deadline
    October 1, 2025
    NAICS Code
    541715AI guide
    State
    DC
    ZIP Code
    20515
    AI Product/Service
    service

    Description

    Monoclonal Antibodies (mAbs) played a central role in the US response to the outbreaks of important human pathogens such as anthrax, Ebola, RSV and SARS CoV-2. Advancing beyond the demonstrated manufacturing performance of mAbs for a rapid response, BARDA is seeking to improve (enhance) the speed and efficiency of antibody production. This effort is directed at developing and implementing FDA Advanced Manufacturing goals within the antibody manufacturing environment. Innovations of most interest are those that rapidly scale manufacturing capabilities (scalability), create a distributed network of manufacturing sites (portability), improve cost-efficiency of manufacturing processes, and create new tools that can address drug shortages in support of the emergency preparedness and response mission of the Biomedical Advanced Research and Development Authority (BARDA).

    Improvements of consideration in this solicitation apply the use of automation, digitization, and artificial intelligence to; streamline production methods, collection of more process control data, and ultimately design and deployment of smart algorithms that adaptively control or make decisions about production or release.  The effort must be directed at an improvement which can be used across multiple biologics (applicability).

    The effort must be focused on the manufacturing improvement of a product in the BARDA portfolio.

    Strategic oversight for the Project Agreement(s) supported by this RPP will be provided by BARDA.

    Key dates

    1. September 10, 2025Posted Date
    2. October 1, 2025Proposals / Responses Due

    AI search tags

    Frequently asked questions

    ANTIBODY (AB) ADVANCED MANUFACTURING CAPABILITY IMPROVEMENT: SMART TECHNOLOGIES is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.